Digital pathology enables pathologists to collaborate and work remotely on cases by improving the accuracy of diagnostic techniques and allowing the sharing of digital images beyond geographical limitations. Before the outbreak of COVID-19, the adoption of digital pathology was extremely low due to stringent federal regulations of the U.S. FDA. The adoption increased due to the relaxation of FDA requirements for validating and approving digital pathology-related technology to meet the increased demand during the pandemic. Furthermore, the Centers for Medicare & Medicaid Services waived the Clinical Laboratory Improvement Amendments restrictions, allowing pathologists to use digital pathology platforms from their homes.
Read More: https://www.meticulousresearch.....com/product/digital
